[ad_1]
Analytics
Equity – Common
Healthcare & Pharmaceuticals
Aeris Biotechnologies is raising funds through Reg A+ crowdfunding with Dalmore Group as the Broker-Dealer. The company is bringing an innovative and green approach to the treatment of asthma. The business has developed a first-of-its-kind, in-home, and affordable treatment kit to control the dust mites and associated allergens that cause asthma. The technology of Aeris Biotechnologies is green, scalable, and patent-protected. Aaron Michael Gunn and Dr. David Richard Harper founded Aeris Biotechnologies in 2021. The current crowdfunding campaign has a maximum target of $15,000,000. The campaign proceeds will be used for business development, marketing, research and development, product development, and working capital.
Balance Sheet
|
Cash and Cash Equivalents |
$33,242 |
| Total Assets |
$33,242 |
|
Accounts Payable & Accrued Liabilities |
$104,548 |
|
Long Term Debt |
$50,000 |
|
Total Liabilities |
$104,548 |
|
Total Stockholders’ Equity |
$-71,306 |
| Total Liabilities and Equity |
$33,242 |
Statement of Comprehensive Income Information
|
Earnings Per Share – Basic |
$0.00 |
|
Earnings Per Share – Diluted |
$0.00 |
Auditor: BF Borgers CPA PC
Financials as of: 07/26/2022
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd’s quantitative ratings on all raises.
- Plan Includes:
-
Everything in Free, plus
- Company specific
“>
KingsCrowd ratings (excluding risk)
- Advanced company search (
with ratings) 
“>
Markets page filters and historical industry data-
Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd’s qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed
“>
Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports- In-depth risk ratings for every raise
-
Get Edge Pro Annual
Edge Pro
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
Analyst Report 
Thank you for your vote on Aeris Biotechnologies on Dalmore Group 2022
Thank you for your vote on Aeris Biotechnologies on Dalmore Group 2022
[ad_2]